Healthpeak Properties, Inc. Price & Performance (DOC)

Healthpeak Properties reported Q1 2025 adjusted FFO per share of $0.46, matching analyst expectations. Revenues rose nearly 16% year-over-year to $702.9 million. The company maintained its 2025 guidance and saw robust growth in its outpatient medical and lab segments, despite higher interest expenses impacting results. Share buybacks continued.123

Healthpeak’s stock dropped over 5% in the latest session, even as Q1 earnings and revenue surpassed forecasts. The company recently appointed Kelvin Moses as CFO, signaling a focus on operational efficiency. Analysts note challenges in the lab segment but highlight resilience in outpatient medical and senior housing portfolios.456

Analyst sentiment on Healthpeak remains divided, with some downgrades to 'sell' while others maintain 'outperform' ratings. The company’s dividend yield stands near 6.5% and it has repurchased 5.1 million shares so far in 2025. Despite recent stock declines, the diversified healthcare REIT continues to attract both bullish and cautious views.789